86 results on '"Feuer, Eric J"'
Search Results
2. Analyzing discrete competing risks data with partially overlapping or independent data sources and nonstandard sampling schemes, with application to cancer registries
3. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics
4. Early estimates of cancer incidence for 2015: Expanding to include estimates for white and black races
5. Re: Think before you leap
6. The efficacy of prostate‐specific antigen screening: Impact of key components in the ERSPC and PLCO trials
7. Improved confidence interval for average annual percent change in trend analysis
8. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies
9. Early estimates of SEER cancer incidence, 2014
10. Preliminary estimates of SEER cancer incidence for 2013
11. Early estimates of SEER cancer incidence for 2012: Approaches, opportunities, and cautions for obtaining preliminary estimates of cancer incidence
12. Genetic Data Simulators and their Applications: An Overview
13. Genetic Simulation Tools for Post‐Genome Wide Association Studies of Complex Diseases
14. Clustering of trend data using joinpoint regression models
15. Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials
16. Confidence intervals for ranks of age-adjusted rates across states or counties
17. Adjusting for reporting delay in cancer incidence when combining different sets of cancer registries
18. Trends in esophageal adenocarcinoma incidence and mortality
19. Chapter 2: Birth-Cohort-Specific Estimates of Smoking Behaviors for the U.S. Population
20. Chapter 3: Cohort Life Tables by Smoking Status, Removing Lung Cancer as a Cause of Death
21. Chapter 1: The Impact of the Reduction in Tobacco Smoking on U.S. Lung Cancer Mortality, 1975-2000: An Introduction to the Problem
22. The prostate cancer conundrum revisited
23. The Cancer Survival Query System: Making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients
24. Predicting US- and state-level cancer counts for the current calendar year
25. Predicting US- and state-level cancer counts for the current calendar year
26. Predicting the absolute risk of dying from colorectal cancer and from other causes using population-based cancer registry data
27. Next generation analytic tools for large scale genetic epidemiology studies of complex diseases
28. Multiple imputation methods for inference on cumulative incidence with missing cause of failure
29. Authors' Reply
30. Estimating average annual per cent change in trend analysis
31. Breast cancer survivors in the United States
32. Improved survival time: What can survival cure models tell us about population‐based survival improvements in late‐stage colorectal, ovarian, and testicular cancer?
33. Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey
34. Authors' reply
35. Estimates of long‐term survival for newly diagnosed cancer patients
36. Estimating Average Annual Percent Change for Disease Rates without Assuming Constant Change
37. Racial/ethnic patterns in lifetime and age-conditional risk estimates for selected cancers
38. Comparability of Segmented Line Regression Models
39. Cure fraction estimation from the mixture cure models for grouped survival data
40. The prevalence of patients with colorectal carcinoma under care in the U.S.
41. Age-conditional probabilities of developing cancer
42. Estimating the Variance of Disease-Prevalence Estimates from Population-Based Registries
43. Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates
44. Permutation tests for joinpoint regression with applications to cancer rates
45. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival
46. A semi-parametric estimate of extra-Poisson variation for vital rates
47. Author reply
48. CONFIDENCE INTERVALS FOR DIRECTLY STANDARDIZED RATES: A METHOD BASED ON THE GAMMA DISTRIBUTION
49. Prognostic significance of in situ carcinoma associated with invasive breast carcinoma: A natural experiment in cancer immunology?
50. Increasing incidence of childhood cancer: report of 20 years experience from the Greater Delaware Valley Pediatric Tumor Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.